Ciglitazone, Ligand of Peroxisome Proliferator-Activated Receptor-gamma, Inhibits Vascular Endothelial Growth Factor Activity
- 1 April 2002
- journal article
- Published by Wiley in European Surgery
- Vol. 34 (2) , 127-130
- https://doi.org/10.1046/j.1563-2563.2002.02024.x
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Effect of Prostaglandin-J2on VEGF Synthesis Depends on the Induction of Heme Oxygenase-1Antioxidants and Redox Signaling, 2002
- Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPARγ-independent mannerProstaglandins & Other Lipid Mediators, 2001
- Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Retinoblastoma Phosphorylation and G1 → S Transition in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2000
- PPAR‐γ‐Mediated Regulation of Normal and Malignant B Lineage CellsAnnals of the New York Academy of Sciences, 2000
- PPARγ-Ligands Inhibit Migration Mediated by Multiple Chemoattractants in Vascular Smooth Muscle CellsJournal of Cardiovascular Pharmacology, 1999
- Expression of Peroxisome Proliferator-Activated Receptor γ (PPARγ) in Rat Aortic Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1998
- Mechanisms of angiogenesisNature, 1997
- The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiationBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- The RXR heterodimers and orphan receptorsPublished by Elsevier ,1995
- Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured CellsJournal of Biological Chemistry, 1995